Key facts
- Notable investors include Hawk Infinity.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Optipharma
- ·The full record, as it builds
Funding rounds
No funding rounds for Optipharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Optipharma
Provider of neutral contract manufacturing services intended to support the development of whole food and dietary supplements for Norwegian companies. The company offers end-to-end capabilities, including ideation, recipe development, flavor and packaging design, and manufacturing of vegan and organic tablets, powders, liquids, and capsules, enabling clients in Norway to efficiently bring customized wellness products to market.
- Sector
- Business Products and Services (B2B)
- HQ
- Droebak, Norway
- Founded
- 2010
- Employees
- 7
- Website
- optipharma.no/
- Ownership
- Privately Held (backing)
Optipharma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Optipharma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Optipharma in its N-PORT filings yet. We sweep new filings monthly.